Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05118048 · ClinicalTrials.gov registry record
StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood
A clinical trial, sponsored by Nova Biomedical.
- Terminated
- Registry status
- 285
- Enrollment target
NCT05118048 is a clinical trial that was terminated before completion, run by Nova Biomedical. The registered enrollment target is 285 participants.
The verdict
NCT05118048 was terminated before completion, sponsored by Nova Biomedical.
- TERMINATED
- Registry status
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical utility of the StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System in the testing of whole blood specimens from patients in hospital settings by CLIA waived operators, over a period of at least twenty days. The specimens shall include capillary (obtained by fingerstick), and venous whole blood. The study will also evaluate the use of a Fingerstick Blood Contamination Barrier for capillary sampling from the fingertip. This submission to the FDA is intended for a Point of Care (POC), CLIA waived device for whole blood capillary and venous lactate, and hemoglobin and hematocrit measurements.
Interventions
- DIAGNOSTIC_TEST Lactate, Hemoglobin, Hematocrit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2021-01-18 |
| Est. Completion | 2021-10-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05118048
The ClinicalTrials.gov registry entry for NCT05118048 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Biomedical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactate, Hemoglobin, Hematocrit is the first listed.
NCT05118048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05118048 about?
NCT05118048 is a clinical study titled "StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood". The purpose of this study is to evaluate the clinical utility of the StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System in the testing of whole blood specimens from patients in hospital settings by CLIA waived operators, over a period of at least twenty days. The specimens shall incl...
What is the current status of trial NCT05118048?
This trial is currently terminated. The enrollment target is 285 participants. The study started on 2021-01-18. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT05118048?
The interventions under investigation include: Lactate, Hemoglobin, Hematocrit (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05118048?
This trial is sponsored by Nova Biomedical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.